Literature DB >> 19395962

Transendothelial lipoprotein transport and regulation of endothelial permeability and integrity by lipoproteins.

Arnold von Eckardstein1, Lucia Rohrer.   

Abstract

PURPOSE OF REVIEW: Previously, the endothelium was considered as a passive exchange barrier of lipoproteins between plasma and extravascular tissues. This dogma is challenged by recent findings on a dual relationship between lipoproteins and endothelial permeability. RECENT
FINDINGS: LDL and HDL as well as apolipoprotein A-I pass the intact endothelium through transcytosis by processes, which involve caveolin-1, the LDL-receptor, ATP-binding cassette transporters A1 and G1 or scavenger receptor BI. Moreover, HDL help the endothelium to maintain structural integrity and hence selective permeability for biomolecules by keeping interendothelial junctions closed, by inhibiting endothelial cell apoptosis and by stimulating endothelial proliferation, migration and tube formation as well as the recruitment and differentiation of endothelial progenitor cells in damaged parts of the endothelium. Both apolipoprotein A-I and sphingosin-1-phosphate mediate many of the protective effects of HDL on the endothelium by interacting with endothelial scavenger receptor BI and sphingosin-1-phosphate receptors, respectively, and by activating intracellular signalling cascades, including the small G protein Rac, src-kinase, phosphoinositol 3 kinase, protein kinase B (Akt) and mitogen-activated protein kinases.
SUMMARY: The endothelium actively controls the trafficking of lipoproteins between intravascular and extravascular compartments. In addition, lipoproteins affect the integrity and permeability of the endothelium.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19395962     DOI: 10.1097/MOL.0b013e32832afd63

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  28 in total

1.  Endothelial caveolae and caveolin-1 as key regulators of atherosclerosis.

Authors:  Philippe G Frank
Journal:  Am J Pathol       Date:  2010-06-25       Impact factor: 4.307

2.  High HDL cholesterol level after treatment with pitavastatin is an important factor for regression in carotid intima-media thickness.

Authors:  Kenji Okumura; Hideto Tsukamoto; Hideyuki Tsuboi; Haruo Hirayama; Haruo Kamiya; Masato Watarai; Ryoji Ishiki; Toyoaki Murohara
Journal:  Heart Vessels       Date:  2014-01-24       Impact factor: 2.037

3.  Enhanced vascular permeability facilitates entry of plasma HDL and promotes macrophage-reverse cholesterol transport from skin in mice.

Authors:  Ilona Kareinen; Lídia Cedó; Reija Silvennoinen; Pirkka-Pekka Laurila; Matti Jauhiainen; Josep Julve; Francisco Blanco-Vaca; Joan Carles Escola-Gil; Petri T Kovanen; Miriam Lee-Rueckert
Journal:  J Lipid Res       Date:  2014-12-03       Impact factor: 5.922

4.  Carboxyl terminus of apolipoprotein A-I (ApoA-I) is necessary for the transport of lipid-free ApoA-I but not prelipidated ApoA-I particles through aortic endothelial cells.

Authors:  Pascale M Ohnsorg; Lucia Rohrer; Damir Perisa; Andreas Kateifides; Angeliki Chroni; Dimitris Kardassis; Vassilis I Zannis; Arnold von Eckardstein
Journal:  J Biol Chem       Date:  2011-01-05       Impact factor: 5.157

Review 5.  High-density lipoprotein and atherosclerosis: Roles of lipid transporters.

Authors:  Yoshinari Uehara; Keijiro Saku
Journal:  World J Cardiol       Date:  2014-10-26

6.  Endothelial expression of human ABCA1 in mice increases plasma HDL cholesterol and reduces diet-induced atherosclerosis.

Authors:  Boris L Vaisman; Stephen J Demosky; John A Stonik; Mona Ghias; Cathy L Knapper; Maureen L Sampson; Cuilian Dai; Stewart J Levine; Alan T Remaley
Journal:  J Lipid Res       Date:  2011-10-27       Impact factor: 5.922

7.  Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease.

Authors:  Christian Besler; Kathrin Heinrich; Lucia Rohrer; Carola Doerries; Meliana Riwanto; Diana M Shih; Angeliki Chroni; Keiko Yonekawa; Sokrates Stein; Nicola Schaefer; Maja Mueller; Alexander Akhmedov; Georgios Daniil; Costantina Manes; Christian Templin; Christophe Wyss; Willibald Maier; Felix C Tanner; Christian M Matter; Roberto Corti; Clement Furlong; Aldons J Lusis; Arnold von Eckardstein; Alan M Fogelman; Thomas F Lüscher; Ulf Landmesser
Journal:  J Clin Invest       Date:  2011-06-23       Impact factor: 14.808

8.  Effects and mechanisms of indol-2,3-dione on atherosclerosis.

Authors:  Zhantao Liu; Xuying Ren; Zhihong Yang; Yongjuan Zhao; Lixia Ji; Jing Li; Wang Yue
Journal:  Int J Clin Exp Med       Date:  2014-08-15

Review 9.  HDL and endothelial protection.

Authors:  A Tran-Dinh; D Diallo; S Delbosc; L Maria Varela-Perez; Q B Dang; B Lapergue; E Burillo; J B Michel; A Levoye; J L Martin-Ventura; O Meilhac
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

10.  A novel assay uncovers an unexpected role for SR-BI in LDL transcytosis.

Authors:  Susan M Armstrong; Michael G Sugiyama; Karen Y Y Fung; Yizhuo Gao; Changsen Wang; Andrew S Levy; Paymon Azizi; Mark Roufaiel; Su-Ning Zhu; Dante Neculai; Charles Yin; Steffen-Sebastian Bolz; Nabil G Seidah; Myron I Cybulsky; Bryan Heit; Warren L Lee
Journal:  Cardiovasc Res       Date:  2015-09-02       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.